Approved Audited Financial Results (Standalone & Consolidated) for the Fourth Quarter and Year ended on 31st March, 2026 and Recommended Final dividend of Rs. 5.00 (50%) per Equity Share ....
EPIGRAL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Epigral Ltd reported audited results for FY2025-26 (year ended March 31, 2026). Revenue from operations declined marginally to Rs. 2,527.18 Cr from Rs. 2,550.13 Cr in the previous year. Profit After Tax (PAT) fell 6.6% to Rs. 333.01 Cr vs Rs. 356.70 Cr, though this was partially supported by a one-time deferred tax credit of Rs. 80.87 Cr following the company's switch to lower tax regime under Section 115BAA. Without this benefit, profitability would have declined more sharply. Finance costs increased significantly to Rs. 71.96 Cr from Rs. 53.27 Cr (up 35%), pressuring bottom-line performance. EBITDA margin compressed from approximately 21.2% to 13.5%. The Board recommended a final dividend of Rs. 5 per share (50%). Auditors issued unmodified (clean) opinions on both standalone and consolidated results. The company invested Rs. 21.38 Cr in a green power associate during the year.
The decline in annual profitability despite flat revenue, combined with rising finance costs and margin compression, signals pressure on operational efficiency. The stock may face negative sentiment near-term despite the dividend announcement, as underlying earnings before tax dropped 36.7% year-on-year.